[go: up one dir, main page]

AUPQ622600A0 - Treatment and/or prevention of ocular pain - Google Patents

Treatment and/or prevention of ocular pain

Info

Publication number
AUPQ622600A0
AUPQ622600A0 AUPQ6226A AUPQ622600A AUPQ622600A0 AU PQ622600 A0 AUPQ622600 A0 AU PQ622600A0 AU PQ6226 A AUPQ6226 A AU PQ6226A AU PQ622600 A AUPQ622600 A AU PQ622600A AU PQ622600 A0 AUPQ622600 A0 AU PQ622600A0
Authority
AU
Australia
Prior art keywords
prevention
treatment
ocular pain
ocular
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ6226A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unisearch Ltd
Original Assignee
Unisearch Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unisearch Ltd filed Critical Unisearch Ltd
Priority to AUPQ6226A priority Critical patent/AUPQ622600A0/en
Publication of AUPQ622600A0 publication Critical patent/AUPQ622600A0/en
Priority to AU2001239005A priority patent/AU2001239005A1/en
Priority to PCT/AU2001/000284 priority patent/WO2001068082A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AUPQ6226A 2000-03-15 2000-03-15 Treatment and/or prevention of ocular pain Abandoned AUPQ622600A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPQ6226A AUPQ622600A0 (en) 2000-03-15 2000-03-15 Treatment and/or prevention of ocular pain
AU2001239005A AU2001239005A1 (en) 2000-03-15 2001-03-15 Treatment and/or prevention of ocular pain
PCT/AU2001/000284 WO2001068082A1 (en) 2000-03-15 2001-03-15 Treatment and/or prevention of ocular pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ6226A AUPQ622600A0 (en) 2000-03-15 2000-03-15 Treatment and/or prevention of ocular pain

Publications (1)

Publication Number Publication Date
AUPQ622600A0 true AUPQ622600A0 (en) 2000-04-06

Family

ID=3820324

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ6226A Abandoned AUPQ622600A0 (en) 2000-03-15 2000-03-15 Treatment and/or prevention of ocular pain

Country Status (2)

Country Link
AU (1) AUPQ622600A0 (en)
WO (1) WO2001068082A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5586579B2 (en) 2008-04-04 2014-09-10 ネクシスビジョン， インコーポレイテッド Treatment device for pain management and vision
CN101264074B (en) * 2008-04-23 2010-09-08 赖福平 Obuvacaine hydrochloride gel and preparation method thereof
JP2010024223A (en) * 2008-06-16 2010-02-04 Teikoku Seiyaku Co Ltd Oxybuprocaine-containing analgesic/antipruritic preparation for external use
EP2316420B1 (en) * 2009-10-22 2014-02-26 Consorzio Universitario Unifarm Topical ophthalmic composition to reduce pain
WO2011050365A1 (en) 2009-10-23 2011-04-28 Forsight Labs, Llc Conformable therapeutic shield for vision and pain
NO2490635T3 (en) 2009-10-23 2018-02-03
US8591025B1 (en) 2012-09-11 2013-11-26 Nexisvision, Inc. Eye covering and refractive correction methods for LASIK and other applications
EP2632405A4 (en) 2010-10-25 2016-02-24 Nexisvision Inc Methods and apparatus to identify eye coverings for vision
US12044905B2 (en) 2011-04-28 2024-07-23 Journey1 Inc Contact lenses for refractive correction
EP2701644B1 (en) 2011-04-28 2018-05-30 Nexisvision, Inc. Eye covering having improved tear flow, comfort, and/or applicability
US9465233B2 (en) 2012-04-20 2016-10-11 Nexisvision, Inc. Bimodular contact lenses
CN104335104B (en) 2012-04-20 2017-06-09 内希斯视觉股份有限公司 Contact lenses for refractive correction
CA2916885A1 (en) 2013-06-26 2014-12-31 Nexisvision, Inc. Contact lenses for refractive correction
US9341864B2 (en) 2013-11-15 2016-05-17 Nexisvision, Inc. Contact lenses having a reinforcing scaffold
WO2015116559A1 (en) 2014-01-29 2015-08-06 Nexisvision, Inc. Multifocal bimodulus contact lenses
US20170073465A1 (en) 2014-02-28 2017-03-16 Michigan Molecular Institute Sustained release composition using biobased biodegradable hyperbranched polyesters

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4997853A (en) * 1988-12-02 1991-03-05 Galenpharma, Inc. Method and compositions utilizing capsaicin as an external analgesic
US5008289A (en) * 1988-12-02 1991-04-16 Galenpharma, Inc. Composition for treating nasal disorders and headaches
US6239180B1 (en) * 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US5854291A (en) * 1996-04-23 1998-12-29 Medical Merchandising, Inc. Pain reliever and method of use
US5885597A (en) * 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain
JP4489289B2 (en) * 1998-02-27 2010-06-23 シンクロニュ−ロン，エルエルシ− Method for treating an anal pain condition and composition therefor

Also Published As

Publication number Publication date
WO2001068082A1 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
WO2001078781A8 (en) Methods for prevention and treatment of gastrointestinal disorders
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
AUPQ622600A0 (en) Treatment and/or prevention of ocular pain
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
AU2001259085A1 (en) Treatment of ocular neovascularization and related diseases
AU2001278981A1 (en) Prevention and treatment of sexual arousal disorders
IL138692A0 (en) Treatment and prevention of vascular disease
AU3896900A (en) Treatment of pain
AU6887101A (en) Copolymers and methods of treating prion-related diseases
AU1794801A (en) Method for treatment and prevention of physiological shock
GB2360453B (en) Treatment of skin conditions
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2964199A (en) Prevention and treatment of adhesions
AU2566201A (en) Compounds and methods for the treatment of pain
AU2001239005A1 (en) Treatment and/or prevention of ocular pain
AU2001267177A1 (en) Diagnosis and treatment of herpes infections
AU3735900A (en) Methods of treatment and prevention of restenosis
AU1392601A (en) Prevention and treatment of biomaterial-associated infections
AU2420201A (en) Compounds and methods for the treatment of pain
ZA200103250B (en) The treatment of immunomodulatory related and other diseases or conditions.
AU2001229479A1 (en) Prevention and treatment of endotoxemia and related complications associated with surgery

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 3900501

Country of ref document: AU